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        Several studies have highlighted the use of rapid influenza 
testing to improve early detection of epidemics and conduct 
outbreak responses.  1,  2   Rapid influenza testing can be used to 
identify patients with influenza in a timely manner and influ-
ence clinical treatment.  3,  4   Although rapid testing for influenza 
has been demonstrated to be less sensitive when compared 
with the polymerase chain reaction (PCR),  5   it could be an 
attractive diagnostic tool in resource-limited settings lack-
ing laboratory capabilities to identify influenza by culture 
or molecular techniques. There is limited data on the use of 
rapid influenza testing in Southeast Asia and regions where 
numerous etiologies of acute febrile illness are endemic 
and could require prompt treatment (e.g., malaria, dengue, 
typhoid fever). 
  Hospital-based and clinic based influenza surveillance was 
established to ascertain the etiologies contributing to acute 
febrile illness in patients in Cambodia.  6   We report the per-
formance of a rapid influenza test conducted at the sites of 
enrollment to identify influenza as an etiology of febrile illness 
during December 2006–May 2008 in Cambodia. Outpatients 
were initially recruited from two referral hospitals, but dur-
ing the course of the study, seven additional healthcare facili-
ties were added; two in August 2007, one in October 2007, one 
in December 2007, one in February 2007, one in March 2008, 
and one in April 2008. Study sites were located ≤ 50 km of 
Phnom Penh in southcentral Cambodia. 
  Patients were clinically evaluated by a physician or medi-
cal assistant and recruited for study participation if they met 
inclusion criteria: at least 24 hours of fever (a measured tym-
panic membrane temperature > 38.0°C), were ≥ 2 years of age, 
and after medical examination, had no obvious source of infec-
tion. Influenza-like illness was defined as fever (> 38.0°C) with 
cough and/or sore throat. Eligible subjects voluntarily enrolled 
in accordance with an Institutional Review Board protocol 
approved by U.S. Naval Medical Research Unit No. 2 in com-
pliance with all applicable Federal regulations governing the 
protection of human subjects and the National Ethics Commit-
tee of the Royal Kingdom of Cambodia, Ministry of Health. 
  For each enrolled patient, one throat and one nasal swab 
was collected and placed in a vial containing 2–3 mL of virus 
transport medium. All inoculated vials were kept at 4°C 
until received by the laboratory 24–72 hours after collection. 
Medical personnel were trained by study investigators by 
using the manufacturer’s instructions on the proper collection 
of a nasopharyngeal swab and interpretation of the QuickVue 
Influenza A+B Test (Quidel Inc., San Diego, CA). Color digi-
tal photographs of all rapid test results were taken and for-
warded for laboratory supervisor’s confirmation. RNA was 
extracted from nasal and throat swabs by using QIAamp viral 
RNA mini kits (QIAGEN, Hilden, Germany) according to 
the manufacturer’s instruction and stored at –70°C. Influenza 
virus genome was detected by using a reverse real-time PCR 
(Centers for Disease Control and Prevention, Atlanta, GA) 
developed to detect influenza A and B viruses and influ-
enza A viruses of H1, H3, and H5 subtypes and performed as 
described.  6  
  A total of 1,327 patients were enrolled during December 
2006–May 2008. Among the participants, the median age was 
10 years (interquartile range [IQR] = 5–22 years) and 50% 
were male. The median time of illness prior to presentation 
for healthcare services was 3 days (IQR = 2–3 days). During 
this period, 261 (19.7%) enrollees were identified as influenza 
positive by RT-PCR, and 147 participants were influenza posi-
tive by rapid test. Among the 147 rapid test–positive results, 
136 had concordant results by RT-PCR. Overall, the sensitiv-
ity and specificity of the Quickvue influenza rapid test com-
pared with PCR was 52.1% and 92.5%, respectively. Among 
the 136 concordant results, 72 (52.9%) were influenza A and 
64 (47.1%) were influenza B. Sensitivity for influenza A and B 
was 47% and 57%, respectively. One case identified as rapid 
influenza A positive at the field site was later confirmed to be 
influenza B. 
  Among PCR-positive influenza patients, the median age of 
rapid test–positive patients was 8 years (IQR = 5–12 years) and 
the median age of rapid test–negative patients was 10 years 
(IQR = 5–17 years). There was a significant difference between 
the sensitivities of the rapid test between age groups, 56.9% 
among patients 2–18 years of age and 22.2% among patients 
> 18 years of age (  P   = 0.0001). The median day of presenta-
tion for health care services was 3 days for rapid test positive-
patients (IQR = 2–3 days) and rapid test–negative patients 
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(IQR = 2.5–4 days). A comparison based on day of fever pre-
sentation identified a significant difference among patients 
presenting at days 0–3 (61.1%) and day 4 (22.4%) ( P  < 0.0001). 
There was no significant difference in rapid test results based 
on a clinical presentation with influenza-like illness; 74.8% of 
rapid test–positive patients and 79.3% of rapid test–negative 
patients had influenza-like illness (  P   = 0.39). 
  Among 1,327 patients enrolled who had an acute febrile 
illness, use of an influenza rapid test resulted in 136 (10.2%) 
patients who were diagnosed with influenza at the time of 
their health care visit. During the peak of influenza activ-
ity (August–December 2007),  6   influenza rapid tests identi-
fied 20–35% of the acute febrile cases as influenza infections. 
There was a significant difference in the sensitivity of the rapid 
test when used at times of peak influenza activity compared 
with when influenza was not circulating (55.6% versus 25.1%, 
respectively;   P   = 0.002). 
  In this study, the overall sensitivity of the influenza rapid 
test was similar to those of published studies.  5,  7–  9   The cost of 
influenza PCR testing (US $21–25/test) and infrastructure 
requirements prevent its routine clinical use in Cambodia. 
A laboratory-based surveillance program that monitors influ-
enza activity in a region could determine times to implement 
rapid testing beyond the influenza surveillance sentinel sites 
to help manage and diagnose illnesses. Limiting the use of 
rapid tests (US $7–12/test)  10   to times determined by a labo-
ratory-based surveillance program would be a more cost-
effective alternative than year-round testing. 
  This study was conducted in a region endemic to several 
causes of acute febrile illness (e.g.,  dengue, malaria, typhoid) 
that can present with similar symptoms and can make a clini-
cal diagnosis of disease difficult. This study suggests that rapid 
influenza tests may be useful during peak times of influenza 
activity or during outbreaks in an area where several different 
etiologies can present as an acute febrile illness. 
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